OMERS ADMINISTRATION Corp Purchases 10,167 Shares of The Clorox Company $CLX

OMERS ADMINISTRATION Corp raised its position in shares of The Clorox Company (NYSE:CLX) by 228.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,609 shares of the company’s stock after acquiring an additional 10,167 shares during the period. OMERS ADMINISTRATION Corp’s holdings in Clorox were worth $1,514,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of CLX. Lombard Odier Asset Management Switzerland SA lifted its position in Clorox by 7.5% during the first quarter. Lombard Odier Asset Management Switzerland SA now owns 108,600 shares of the company’s stock valued at $11,254,000 after purchasing an additional 7,600 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of Clorox by 57.6% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 7,598 shares of the company’s stock worth $787,000 after buying an additional 2,776 shares during the last quarter. Bollard Group LLC increased its holdings in shares of Clorox by 24.7% in the 1st quarter. Bollard Group LLC now owns 16,443 shares of the company’s stock worth $1,704,000 after buying an additional 3,258 shares during the last quarter. Compound Planning Inc. raised its position in shares of Clorox by 15.4% during the 1st quarter. Compound Planning Inc. now owns 2,451 shares of the company’s stock valued at $254,000 after buying an additional 328 shares in the last quarter. Finally, Dickmeyer Boyce Financial Management Inc. bought a new position in shares of Clorox in the 1st quarter valued at about $456,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Down 0.6%

Shares of NYSE:CLX opened at $99.67 on Thursday. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $128.90. The business has a 50 day simple moving average of $95.46 and a two-hundred day simple moving average of $103.79. The firm has a market capitalization of $12.05 billion, a PE ratio of 16.18 and a beta of 0.54. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the prior year, the business posted $1.45 earnings per share. The company’s revenue for the quarter was up .1% on a year-over-year basis. On average, equities analysts predict that The Clorox Company will post 5.52 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Barclays lifted their price target on Clorox from $85.00 to $86.00 and gave the stock an “underweight” rating in a research report on Tuesday, July 21st. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a research note on Friday, July 10th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $94.00 target price on shares of Clorox in a report on Wednesday, July 22nd. Wells Fargo & Company decreased their price target on Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a report on Monday, May 18th. Finally, Evercore restated an “underperform” rating and issued a $98.00 price target on shares of Clorox in a research report on Thursday, July 23rd. Twelve research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Reduce” and an average price target of $101.00.

Insider Buying and Selling

In other Clorox news, Director Pierre R. Breber acquired 5,000 shares of the business’s stock in a transaction on Tuesday, May 5th. The shares were bought at an average price of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. 0.63% of the stock is owned by company insiders.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.